Our objective is to gain a comprehensive understanding of how THY-10A62 inhibits liver cancer cell proliferation through modulation of the FAK signaling pathway, providing a solid foundation for further development of liver cancer therapeutics. The gene discussed is PTK2; the disease is liver cancer.